Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/02 → 6/30/04 |
Funding
- Agouron Pharmaceuticals: $7,860.00
...Study of Capravirine (AG1549) in Combination with VIRACEPT & 2 Nucleoside Reverse Transcriptase Inhibtors in HIV-Infected Patients Who Failed an Initial Nonnucleouside Reverse Transcriptase Inhibitor Containing Regimen
- Greenberg, Richard (PI)